November 27, 2020
Pharmacy Update
Disclaimer: We are getting frequent COVID-related questions about drug concerns and potential interactions. This information is as of November 25, 2020. We will do our best to keep you up to date with this ever evolving situation. This is the most update information at the time of publication.

Note: There are no Food and Drug Administration (FDA) approved therapies for treatment or prevention of COVID-19. If at all possible, it is best to have patients enrolled in a clinical trial.
In this issue:

POTENTIAL COVID-19 VACCINES AND DISTRIBUTION
  • Pfizer and BioNTech Vaccine 
  • Moderna
  • Oxford and AstraZenica
UTSW Physical Medicine & Rehabilitation Referral for COVID-19 Recovery
For patients who are having subacute or chronic symptoms after COVID-19 infection, UT Southwestern Medical Center is offering individualized outpatient rehabilitation programs for patients recovering from COVID-19 infection.
If you would like to refer patients to this program:
  1. Refer your patient for an in-person or virtual care consultation with “COVID RECOVER” in the comments, or call 214-645-2080 (Dallas) or 469-914-9187 (Frisco).
  2. Patients will receive a comprehensive PM&R and cognitive evaluation.
  3. Treatment may include referrals for reconditioning and strengthening, counseling, group psycho-education therapy, and cognitive therapy. 
Contact Us
If you have questions about items in the SWHR COVID-19 News or Southwestern Health Resources, send us an email: SWHRNews@SouthwesternHealth.org →